Clinical and coronary arteriographic findings were evaluated in patients with angina pectoris who were considered not to have diabetes mellitus or to have chemical or clinical diabetes. Each of the three groups consisted of 100 consecutive referred patients. Neither the age of the patients nor duration of symptoms difilered significantly among the groups. Hypertension, gout, and peripheral vascular disease were more frequent in the patients with clinical diabetes. There was no diierence in serum cholesterol concentration among the group, but plasma Mglyceride levels and the frequency of type 4 hyperlipoproteinemia were significantly higher (P < 0.01) in the chemical and clinical diabetic groups than in the non-
Clinical and coronary arteriographic findings were evaluated in patients with angina pectoris who were considered not to have diabetes mellitus or to have chemical or clinical diabetes. Each of the three groups consisted of 100 consecutive referred patients. Neither the age of the patients nor duration of symptoms difilered significantly among the groups. Hypertension, gout, and peripheral vascular disease were more frequent in the patients with clinical diabetes. There was no diierence in serum cholesterol concentration among the group, but plasma Mglyceride levels and the frequency of type 4 hyperlipoproteinemia were significantly higher (P < 0.01) in the chemical and clinical diabetic groups than in the nonelective coronary arteriography has been an important adjunct in evaluation of patients with arteriosclerotic heart and has provided a significant impetus to surgical treatment of some patients with angina p e c t~r i s .~. '~ Several studies"-l4 in patients with arteriosclerotic heart disease have related arteriographic anatomy to risk factors, including age, weight, blood pressure, and blood lipid and glucose levels. Diabetes mellitus is well recognized to be associated with a high incidence of coronary arterial disease.15.16 Furthermore, ~t u d i e s l , l~J~-~~ have demonstrated abnormal glucose tolerance in 69 to 87 percent of patients with coronary arterial disease. Pathologic studies suggest that the severity of coronary arterial disease may be related to both the presence and duration of diabetes mellitus.16.21 Clinical ~t u d i e s~~"~ indicate that the prognosis of coronary arterial disease may be adversely affected by the presence of diabetes mellitus. We studied a large group of patients with angina pectoris and arteriographically documented arteriosclerotic heart disease in order to determine whether the severity of coronary arterial involvement differed in diabetic and nondiabetic subjects, diabetic patients. Coronary arteriographic observations indicated that the severity of the coronary arterial disease was greater in both diabetic groups than in nondiabetic patients. The dPerence in the coronary scores among the three groups of patients interacts to some extent with the 'triglyceride level, since a high score in the diabetic groups was noted only in the presence of an elevated triglyceride concentration. The results indicate that the increased severity of coronary arterial disease in diabetic patients is not attributable to age, duration of symptoms, hypertension, type -4 hyperlipoproteinemia, or apparent severity of the glucose intolerance.
whether severity differed in patients with chemical diabetes and those with clinical diabetes, and whether any Merences could be attributed to age, duration of symptoms, hypertension, or the presence of type -4 hyperlipoproteinemia.
All patients were referred to the Long Eland JewishHillside Medical Center because of angina pectoris and were found to have arteriographic evidence of arteriosclerotic heart disease. Three groups of 100 patients were consecutively sampled from coded optical scanning forms from over 1,500 patients seen and evaluated during a five-year period because of symptomatic coronary arterial disease. One hundred patients who had no family history of diabetes mellitus and had normal glucose tolerance were designated as t h nondiabetic group. Another 100 patients, the group with chemical diabetes, had no prior history of diabetes mellitus and had normal fasting blood glucose levels but abnormal glucose tolerance. Finally, another 100 patients were designated as the group with clinical diabetes. This last group included 78 ~atients with known histories of diabetes mellitus confirmed on admission by elevated fasting blood glucose levels. Fifty-five of these 78 were receiving therapy with antidiabetic drugs; the remaining 23 patients were treated only with &t. The average duration of diabetes mellitus was 7.6 -r-6.9 years ( 2 1 SD). Another 22 patients were found on evaluation to have elevated fasting blood glucose levels and glycosuria during abnormal glucose tolerance tests; these patients were included in the clinical diabetic group along with the 7.8 patients with known histories of diabetes mellitus.
Classification in the nondiabetic group required not only a normal gluco~e tolerance test, but also the absence of any family history of diabetes mellitus. The latter requirement was included in the nondiabetic group because it had pre-viously been demonstrated in patients with a family history of diabetes mellitus that a latent chemical diabetic state may be present in a significant number of such patients, as indicated by an abnormal cortisone-glucose tolerance test.25 Classification in the chemical diabetic group required both a normal fasting blood glucose level and an abnormal glucose tolerance corrected for age. There were some patients excluded from this study who neither had a normal glucose tolerance as defined by Fajans and Corm" nor had an abnormal glucose tolerance as defined by the age-corrected criteria detailed later in this report. These patients were excluded because there was uncertainty as to the group in which they should be included. The majority of patients in the clinical diabetic group had overt diabetes mellitus requiring some form of antidiabetic therapy, while a small number were found on evaluation to have previously unrecognized diabetes mellitus.
All patients were interviewed, examined, and evaluated by one of the authors ( R.I.H.). This history included onset of clinical arteriosclerotic heart disease, be it angina pectoris or myocardial infarction. A history of a myocardial infarction was accepted if documented by the referring doctor or if the patient had a prior hospitalization of at least three weeks for ~rolonged chest pain. A positive history of congestive heart failure was based on a prior hospital admission for congestive heart failure or shortness of breath not associated with angina pectoris requiring digitalis or diuretic therapy, or both. A diagnosis of hypertension required either a history of antihypertensive therapy or a persistent diastolic pressure of 90 mm Hg or over when admitted for evaluation. This included some patients who, when admitted, were normotensive and receiving antihypertension therapy. A positive history of cigarette smoking required the smoking of 20 cigarettes a day or more for at least ten years prior to the onset of symptoms. The diagnosis of peripheral vascular disease was made on the basis of unequal or absent peripheral pulses in the lower extremities and was usually accompanied by a history of intermittent claudication. A familv historv of arteriosclerotic heart disease, hypertension, or diabetes mellitus was noted.
Patients were considered overweight if they were in the 70th percentile or higher for body weight related to their height and sex."
A 12-lead standard electrocardiogram was taken for all patients. A diagnosis of transmural myocardial infarction was made on the basis of accepted criteria.28 Radiologic evaluation and interpretation were performed by a radiologist to define the presence or absence of cardiomegaly. The patients were maintained on a regular diet in the hospital. All drugs were discontinued. Blood samples were drawn from each patient after a 12-hour to 16-hour overnight fast and were analyzed for levels of glucose,29 cholesterol, and triglycerides. 30 The normal range for blood glucose, cholesterol, and triglyceride concentrations by these methods is 85 to 110 mg/ 100 ml, 150 to 300 mg/100 ml, and 50 to 150 mg/100 ml, respectively. Serum levels of lipoproteins were determined by the methods described by Noble31 and typed according to criteria of Fredrickson and Lees. 32 A glucose tolerance test was performed on all patients by orally administering a 100-gm glucose load and obtaining fasting, half-hour, one-hour, two-hour, and three-hour blood specimens. A normal glucose tolerance was based on the criteria defined by Fajans and Corm;% however, because of observations by Andre$ that glucose tolerance is affected by the age of the patient, an abnormal glucose tolerance was considered present for patients less than 50 years of age if the one-hour and two-hour blood glucose levels were above 160 and 120 mg/100 ml, respectively, while for patients 50 years and older, 10 mg/100 ml was added to these values for each decade. Therefore, for a patient 60 years of age, the one-hour and two-hour blood glucose levels would have to be above 180 and 14.0 mg/100 ml, respectively, to be considered abnormal. Utilizing these criteria, patients 50 years of age and older were excluded from this studv if thev did not have a normal glucose tolerance (for nondiabetic group) as defined by Fajans and Con$-nd at the same time did not meet the age-corrected criteria for an abnormal glucose tolerance (for diabetic group). Thus, the nondiabetic group consisted of 100 patients having a normal glucose tolerance as defined by Fajans and Conn,26 while the 100 patients in the group with chemical diabetes had a normal fasting blood glucose level and a glucose tolerance that was abnormal even when age-corrected. The mean ( 5 1 SD) two-hour blood glucose level for the glucose tolerance test in the chemical diabetic group was 165 + 23 mg/100 ml for ages 30 to 39 years, 180 -e 44 mg/100 ml for ages 40 to 49 years, 184 & 40 mg/100 ml for ages 50 to 59 years and 191 30 mg/100 ml for age 60 years and over. The clinical diabetic group consisted of 100 patients with overt diabetes mellitus conk e d by the presence of both an abnormal fasting blood glucose level and an abnormal glucose tolerance test accompanied by varying degrees of glycosuria.
Evaluation of patients was performed by methods previously described.%* Selective coronary arteriograms were obtained in multiple projections with a 35-mm camera at 60 frames per second. The cine f h s were projected with a 35-mm projector (Vanguard Instrument Corp. ), and each of the coronary arteries (left anterior descending, left circumflex, and right coronary arteries) were graded on the basis of a score from 0 to 6 as previously described2 and as defined by Bruschke.34 Using this method, the following grading system was utilized for each coronary artery: grade 0, normal vessel; grade 1, slight wall irregularity, not greater than 30 percent narrowing of lumen; grade 2, from 30 percent to 50 percent narrowing of luminal diameter; grade 3, from 50 percent to 90 percent narrowing of lumen; grade 4, narrowing over 90 percent but not complete; grade 5, total occlusion with distal filling by collateral flow; and grade 6, total occlusion with little or incomplete filling by dista segment. An independent comparison by three of the authors ( R.I.H., J.M., and A.A. ) of a large number of patients using this method of scoring revealed no significant differences. Significant coronary disease was defined as narrowing of a coronary artery by more than 50 percent ( grade 3 or more) of the wall lumen. Singlevessel coronary disease was defined a s significant coronary arterial disease of only one vessel, while double-vessel and triple-vessel disease indicated significant disease of two or three coronary arteries, respectively. The total coronary score was defined as the sum of the scores of the three major coronary arteries. Involvement of the main left coronary artery was considered separately. The results of hemodynamic studies (including pressures and ejection fraction) performed on all patients will be considered in a later communication.
Statistical evaluation of the three groups studied was performed by standard methods35 with the assistance of a statistician.
The clinical profile for the three groups studied is given in Table 1 were present with significantly greater frequency ( P < 0.01 ) in the clinical diabetic group than in the nondiabetic group. Peripheral vascular disease was present in 14 percent of the patients with clinical diabetes, a frequency significantly greater ( P < 0.01) than that of patients with chemical diabetes or with no diabetes. There were no significant differences among the three groups for a history of a myocardial infarction or cigarette smoking or for family history of arteriosclerotic heart disease or hypertension. Congestive heart failure, evidence of a transmural myocardial infarction, cardiomegaly, and overweight were more frequent in the clinically diabetic patients, but these differences were not statistically significant. There were no significant group differences when comparisions were made between the functional disabilities present, ie, exertional, resting angina pectoris. In spite of the small number of female patients present in each group, a comparison between the male and female patients within each group revealed no difference in the clinical profile, except for the absence of gout in the female patients.
Relating the frequency of the various clinical factors to the duration of symptoms revealed that in the clinical diabetic patients the prevalence of peripheral vascular disease increased from 7 percent in pa- tients with symptoms for one ye% or less to 20 percent in patients with symptoms for five years or more. In all groups the frequency of congestive heart failure and evidence of a transmural myocardial infarction were directly related to the duration of symptoms. The mean serum cholesterol levels for the three groups revealed no significant differences, but the plasma triglyceride level was significantly higher ( P < 0.01) in the diabetic groups than in the nondiabetic patients ( Table 2 ). The prevalence of type 4 hyperlipoproteinemia was also significantly higher ( P < 0.01) in both diabetic groups. In contrast, there was no significant difference in the frequency of type 2 hyperlipoproteinemia among the groups.
Coronary arteriographic observations indicated that the severity of the coronary arterial disease, as reflected both by the number of vessels involved with significant disease and by the total coronary score, was greater in the two diabetic groups than in the nondiabetic group. Involvement of the main left coronary artery revealed no group differences (Table 3 ) . Single-vessel disease was more frequent ( P < 0.01) in the nondiabetic group than in the chemical and clinical diabetic groups, while triplevessel disease was more frequent ( P < 0.01) in the diabetic groups (Table 3 ). Such a difference in the number of involved vessels between the diabetic and nondiabetic patients was still evident when comparisons were made on the basis of either duration of symptoms or age of the patients. As noted in Figure 1 , the frequency of single-vessel disease in patients with symptoms for one year or less is significantly higher ( P < 0.01 ) in the noudiabetic patients than in the diabetic groups. Also note that the prevalence of triple-vessel disease was greater in the diabetic groups than in the nondiabetic patients. There was no difference in the total coronary score between the diabetic groups, but this score was significantly higher ( P < 0.01) in the diabetic patients than in the nondiabetic patients (Table 3) . Relating the total coronary score to the duration of symptoms demonstrated that in all groups the total coronary score increased with an increase in duration of symptoms (Fig 2 ) ; however, as noted in Figure 2 , the total coronary score was always less in the nondiabetic group, whatever the duration of symptoms.
The influence of hypertension on the severity of the coronary arterial disease was evaluated because of the increased prevalence of hypertension in the group of patients with clinical diabetes (Table 1) . , In the 51 patients with hypertension and clinical diabetes, single-vessel disease was present in six patients (12 percent), and the mean total coronary score was 10.5 k 3.0, which is not significantly different from that observed in the nonhypertensive patients with clinical diabetes. Similarly, since type 4 hyperlipoproteinemia was found significantly more often in the diabetic groups (Table 2 ) , its influence on the severity of the coronary arterial disease was also evaluated. In the 49 patients with type 4 hyperlipoproteinemia and clinical diabetes, single-vessel disease was present in 11 percent (five) of the patients, and the mean total coronary score was 10.6 * 2.6, which is not significantly different from that observed in the patients not having a type 4 lipoprotein pattern and clinical diabetes. A similar comparison in the chemical diabetic group also revealed no significant difference in the frequency of single-vessel disease and the mean coronary score when patients with a type 4 lipoprotein pattern were compared with the remaining patients. The influence of the serum triglyceride level and the total coronary score was evaluated. For the entire study group of 300 patients, the median triglyceride level was 148 mg1100 ml. The coronary score for each group was determined on the basis of those patients within each group having either a triglyceride level above or below the median triglyceride level (Table  4) . Such an approach was necessary to offset some extremely high triglyceride levels in some of the patients in both of the diabetic groups. There were no significant differences in the coronary scores within each group when a comparison was made be-
Total Coronar Score
( m e a n ! l~~~l 11- tween those patients having a high triglyceride level (above the median ) with those having a triglyceride level less than the median level; however, when comparisons were made among the three groups for the coronary score, significant differences appeared only when dealing with triglyceride levels above the median level (Table 4 ) . Thus, for both the chemical and clinical diabetic groups, the coronary score was significantly higher than the nondiabetic group only when a comparison was made for those with a high triglyceride level. Attempts to evaluate the influence of blood pressure in a similar manner were not feasible, since the blood pressure at admission is influenced by many factors, among which are the emotional state of the patient on admission and his antihypertensive medication.
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This study has considered three well-defined groups of patients, all referred because of symptomatic ischemic heart disease. Some reservations are necessary when evaluating the results of the present study, since this study was based on a selective referral of patients considered by their doctors as clinical candidates for surgical revascularization. The role that preexisting diabetes mellitus and its known complications may have had in the referral of such patients cannot be determined. Comparison of the clinical profile (Table 1 ) of the nondiabetic patients and patients with chemical or clinical diabetes mellitus demonstrated no striking or unexpected differences among them. The increased prevalence of peripheral vascular disease and gout in the clinical diabetic patients could have been a n t i~i p a t e d . '~,~~.~~.~~ The increased frequency of peripheral vascular disease found in the patients with clinical diabetes compared to those with chemical diabetes is consistent with observation^^^,^^ that the frequency of such vascular disease is related to the duration of diabetes mellitus. It can be speculated that the patients with clinical diabetes had abnormal glucose metabolism for a longer time than those with chemical diabetes. A relationship between gout and diabetes mellitus has been previously noted.36 Although diabetic patients tend to be overweight," there was no statistical significance between their weightlheight measurement and that of the nondiabetic group. The increased frequency of hypertension in the clinical diabetic group has been previously noted.38
A relationship between glucose intolerance and abnormal blood lipid levels has been well documented.32.39-45 Although the normal ranges for cholesterol and triglyceride levels will vary with the age of the patients,46 the present study concerned itself with group comparisons in which the mean age of the groups studied were not significanfly different. The present study demonstrates no differences in the mean cholesterol levels for the groups studied; the diabetic groups had higher triglyceride levels than the nondiabetic patients ( Table 2) , a finding similar to that observed by Reaven and associates.*l The association of type 4 hyperlipoproteinemia with impaired glucose tolerance32 and clinical diabetes45 is well appreciated. The finding of an equivalent number of patients with type 4 hyperlipoproteinemia in each of the diabetic groups suggests that the severity of glucose intolerance is not related to the hyperlipemia.
In the present study, we used selective coronary arteriographic studies to determine both the number of coronary vessels involved and the total coronary score as a reflection of the severity of coronary disease. These indices indicated that the diabetic groups had more severe disease than the nondiabetic subjects ( Table 3 ) . This corroborates pathologic obs e r v a t i o n~~~.~~.~~ that coronary arterial disease is more severe in diabetic patients. Thus, sampling the stage of coronary arterial disease characterized by angina pectoris ( as in the present study) or the endstage (as in the pathologic studies) indicates that the diabetic state is accompanied by a more severe degree of coronary arterial involvement. Taking into account the age, duration of symptoms, or type 4 hyperlipoproteinemia in all the groups in no way altered the distribution of the number of vessels involved or the total coronary score.
Although it has been reported that coronary arterial disease in diabetic patients is adversely affected by hyperten~ion,'~.~~ the present study suggests that hypertension does not affect the severity of coronary arterial disease. The influence of the level of the blood pressure could not be evaluated, since some patients were receiving antihypertensive therapy, and prior elevated blood pressures may be influenced by transmural myocardial infarction. Thus, the influence of hypertension on the severity of the coronary arterial disease in the present study is believed to be inconclusive. Type 4 lipoprotein pattern, which was present in almost half of the patients in the diabetic groups, did not affect the distribution of the number of vessels involved or the coronary score; however, the present study indicates that the difference in severity of the coronary arterial disease among the three groups of patients interacts to some extent with the level of the triglycerides (Table 4) , since the diabetic groups only had a significantly high coronary score in the presence of a high triglyceride level. Of further note is the observation that an elevated triglyceride concentration by itself did not appear to influence the coronary score in all of the three groups. Thus, our results in testing a population of patients referred because of angina pectoris indicate that patients with abnormalities of glucose tolerance are more likely to have severe coronary arterial disease than patients with normal glucose tolerance. Clinical studies22-24,36 reveal that the prognosis of coronary arterial disease is adversely affected by diabetes mellitus. Diabetic patients with angina pectoris have a poorer prognosis than their nondiabetic counterpart^.^^ Furthermore, the mortality during acute myocardial infarction and the five-year life expectancy after acute myocardial infarction are iduenced adversely by the presence of diabetes m e l l i t u~.~~"~,~~ These clinical findings are consistent with the results of the present study, which indicate the increased severity of coronary arterial disease accompanying the diabetic state.
Both pathologic15J6 and clinical s t u d i e~~~.~~ indicate that the prevalence of vascular complications is related to the duration of the diabetes mellitus. In the present study, if it is assumed that the patients with clinical diabetes had abnormal glucose tolerance for a longer time than those with chemical diabetes, then the duration of the abnormal glucose metabolism cannot explain the severity of the coronary arterial disease, since both groups had equal severity of the coronary arterial disease. Previous workers have described arteriosclerotic heart disease17. 18.49 and other vascular disorders50 associated with a preclinical diabetic state. Our results suggest that there is increased severity of coronary arterial disease in such patients and that the severity in diabetic patients as a whole is unrelated to the severity of the glucose intolerance.
